Symptomatic Cardiac Events in Patients with Lung Tumors Near The Heart Treated with Stereotactic Ablative Radiotherapy (SABR): A Single Institution Experience

被引：0
|
作者：
Ko, R. B. [1 ]
Jani, K. [2 ]
Sodji, Q. [2 ]
Merriott, D. J. [3 ]
Pickthorn, W. [2 ]
Bush, K. [1 ]
Maxim, P. G. [4 ]
Diehn, M. [5 ]
Loo, B. W., Jr. [1 ]
机构：
[1] Stanford Canc Inst, Dept Radiat Oncol, Stanford, CA USA
[2] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA
[3] UC Irvine, Sch Med, Irvine, CA USA
[4] Stanford Canc Inst, Dept Radiat Oncol, Indianapolis, IN USA
[5] Dept Radiat Oncol, Stanford, CA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.151
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1071
引用
收藏
页码：S148 / S148
页数：1
相关论文
共 50 条
  • [41] Stereotactic Ablative Radiotherapy for non-spinal bone metastasis. A single institution experience
    Acosta Rojas, A.
    Nunez, M.
    Montero-Luis, A.
    Sanchez-Saugar, E.
    Hernando-Requejo, O.
    Ciervide-Jurio, R.
    Lopez-Gonzalez, M.
    Garcia-Aranda, M.
    Valero-Albarran, J.
    Rubio-Rodriguez, M. C.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S877 - S878
  • [42] Lung stereotactic body radiotherapy after past ablative therapy: a single institution case series
    Wegner, Rodney E.
    Ahmed, Nissar
    Hasan, Shaakir
    Schumacher, Lana Y.
    Colonias, Athanasios
    LUNG CANCER MANAGEMENT, 2018, 7 (03)
  • [43] Linac-based stereotactic ablative radiotherapy for lung cancer: single-institution outcomes
    Ariyaratne, H.
    Scott, E.
    Anderson, A.
    Cooper, E.
    Pasciuti, K.
    LUNG CANCER, 2020, 139 : S32 - S33
  • [44] Local Control Rates With Stereotactic Body Radiotherapy (sbrt) For Primary Lung Tumors: Single Institution Experience Of 153 Consecutive Patients
    Singh, D. P.
    Milano, M. T.
    Hare, M. Z.
    Joyce, N.
    Smudzin, T.
    Chen, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S311 - S312
  • [45] Can Clinical Variables be used to Provide Better Follow up in Stereotactic Ablative Radiotherapy (SABR) Treated Lung Cancers?
    Hatton, N.
    Saha, A.
    Beasley, M.
    Franks, K.
    Clarke, K.
    Jain, P.
    Teo, M.
    Murray, P.
    Lilley, J.
    Dickinson, P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S142 - S142
  • [46] Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) - An analysis of UK's largest cohort of lung SABR patients
    Saha, Animesh
    Beasley, Matthew
    Hatton, Nathaniel
    Dickinson, Peter
    Franks, Kevin
    Clarke, Katy
    Jain, Pooja
    Teo, Mark
    Murray, Patrick
    Lilley, John
    RADIOTHERAPY AND ONCOLOGY, 2021, 156 : 153 - 159
  • [47] Stereotactic Ablative Radiotherapy (SABR) in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer: Outcomes for the First UK SABR Cohort
    Murray, L.
    Ramasamy, S.
    Lilley, J.
    Snee, M.
    Clarke, K.
    Musunuru, H. B.
    Needham, A.
    Turner, R.
    Sangha, V.
    Flatley, M.
    Franks, K.
    CLINICAL ONCOLOGY, 2016, 28 (01) : 4 - 12
  • [48] Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study
    Nathan A Cannon
    Puneeth Iyengar
    Hak Choy
    Robert Timmerman
    Jeffrey Meyer
    BMC Cancer, 14
  • [49] Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study
    Cannon, Nathan A.
    Iyengar, Puneeth
    Choy, Hak
    Timmerman, Robert
    Meyer, Jeffrey
    BMC CANCER, 2014, 14
  • [50] The impact of 'day zero' image verification sessions for patients receiving lung stereotactic ablative radiotherapy: a single institution audit
    Pang, Jennifer
    Lamont, Karen
    Ezhil, Veni
    LUNG CANCER, 2021, 156 : S64 - S64
12345